Assignment of Assignor's Interest

Recorded: 2008-11-26 Pages: 114

Assignor

Executed: 2007-11-13

Assignee

BAYER HEALTHCARE LLC

555 WHITE PLAINS ROAD, TARRYTOWN, NEW YORK, 10591

Covered Properties (10)

Fusion Bonding of Catheter Components

Patent: 6,596,217 →

Application: 09/458,548 →

Inhibition of Raf Kinase Using Quinolyl, Isoquinolyl or Pyridyl Ureas

Patent: 7,928,239 →

Application: 09/777,920 →

Publication: US 2002/0165394

Omega-Carboxyaryl Substituted Diphenyl Ureas as Raf Kinase Inhibitors

Patent: 7,351,834 →

Application: 09/889,227 →

Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Application: 09/948,915 →

Publication: US 2002/0042517

Omega-Carboxyaryl Substituted Diphenyl Ureas as Raf Kinase Inhibitors

Patent: 8,124,630 →

Application: 09/993,647 →

Publication: US 2003/0181442

Omega-Carboxyaryl Substituted Diphenyl Ureas as Raf Kinase Inhibitors

Patent: 7,235,576 →

Application: 10/042,203 →

Omega-Carboxyaryl Substituted Diphenyl Ureas as Raf Kinase Inhibitors

Application: 10/042,226 →

Publication: US 2003/0207872

Hydroxy, W-Carboxyaryl Substituted Diphenyl Ureas and Dirivatives Thereof as Raf Kinase Inhibitors

Patent: 7,528,255 →

Application: 10/071,248 →

Publication: US 2003/0139605

Inhibition of Raf Kinase Using Quinolyl, Isoquinolyl or Pyridyl Ureas

Application: 10/125,369 →

Publication: US 2003/0207914

Omega-Carboxyaryl Substituted Diphenyl Ureas as Raf Kinase Inhibitors

Application: 11/768,104 →

Publication: US 2008/0108672

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.